CAS: 688050-42-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
N-(3-Carbamoyl-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-5-(4-fluorophenyl)isoxazole-3-carboxamide REF: AN-AG02AKAGCAS: 688050-42-2 | 98% | 127.00 €~153.00 € | Thu 11 Jul 24 | |
BCR-ABL-IN-7 REF: TM-T72958CAS: 688050-42-2 | 98.28% | 35.00 €~88.00 € | Fri 12 Jul 24 |
N-(3-Carbamoyl-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-5-(4-fluorophenyl)isoxazole-3-carboxamide
CAS:688050-42-2
Formula:
C19H16FN3O3S
Purity:
98%
Molecular weight:
385.4120
Ref: AN-AG02AKAG
100mg | 127.00 € | ||
250mg | 153.00 € |
Estimated delivery in United States, on Thursday 11 Jul 2024
BCR-ABL-IN-7
CAS:688050-42-2
BCR-ABL-IN-7 is a WT and T315I mutant ABL kinase inhibitor.BCR-ABL-IN-7 potently inhibits WT and T315I …
Formula:
C19H16FN3O3S
Purity:
98.28%
Color and Shape:
Solid
Molecular weight:
385.41
- Inhibitors
- Angiogenesis
- Bcr-Abl
- Tyrosine Kinase/Adaptors
- See more categories
- Cytoskeletal Signaling
Ref: TM-T72958
5mg | 35.00 € | ||
10mg | 48.00 € | ||
25mg | 67.00 € | ||
50mg | 88.00 € |
Estimated delivery in United States, on Friday 12 Jul 2024